Original Article

You have full text access to this OnlineOpen article

Inhibition of adjuvant-induced arthritis by interleukin-10-driven regulatory cells induced via nasal administration of a peptide analog of an arthritis-related heat-shock protein 60 T cell epitope

  1. Berent J. Prakken1,
  2. Sarah Roord1,
  3. Peter J. S. Van Kooten2,
  4. Josée P. A. Wagenaar2,
  5. Willem Van Eden2,
  6. Salvatore Albani3,
  7. Marca H. M. Wauben2,*

Article first published online: 11 JUL 2002

DOI: 10.1002/art.10366

Issue

Arthritis & Rheumatism

Arthritis & Rheumatism

Volume 46, Issue 7, pages 1937–1946, July 2002

Additional Information

How to Cite

Prakken, B. J., Roord, S., Van Kooten, P. J. S., Wagenaar, J. P. A., Van Eden, W., Albani, S. and Wauben, M. H. M. (2002), Inhibition of adjuvant-induced arthritis by interleukin-10-driven regulatory cells induced via nasal administration of a peptide analog of an arthritis-related heat-shock protein 60 T cell epitope. Arthritis & Rheumatism, 46: 1937–1946. doi: 10.1002/art.10366

Author Information

  1. 1

    University of California San Diego, La Jolla, California, and University Medical Center Utrecht, Utrecht, The Netherlands

  2. 2

    Utrecht University, Utrecht, The Netherlands

  3. 3

    University of California San Diego, La Jolla, California, and Androclus Therapeutics, Milan, Italy

*Department of Infectious Diseases & Immunology, Utrecht University, Faculty of Veterinary Medicine, PO Box 80165, 3508 TD Utrecht, The Netherlands

Publication History

  1. Issue published online: 11 JUL 2002
  2. Article first published online: 11 JUL 2002
  3. Manuscript Accepted: 11 MAR 2002
  4. Manuscript Received: 17 SEP 2001

Funded by

  • NIH. Grant Numbers: AR-40770, AR-44850, AI-37232, AR-41897
  • “Ter Meulenfonds” of the Royal Netherlands Academy of Arts and Sciences
  • Dutch Rheumatoid Arthritis Foundation
  • Royal Netherlands Academy of Arts and Sciences

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (208K)

REFERENCES

  • 1
    Metzler B, Wraith DC. Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int Immunol 1993; 5: 1159–65.
  • 2
    Hoyne GF, O'Hehir RE, Wraith DC, Thomas WR, Lamb JR. Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice. J Exp Med 1993; 178: 1783–8.
  • 3
    Higgins PJ, Weiner HL. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J Immunol 1988; 140: 440–5.
  • 4
    Zhang JA, Davidson L, Eisenbarth G, Weiner HL. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci U S A 1991; 88: 10252–6.
  • 5
    Thompson HS, Staines NA. Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats. Clin Exp Immunol 1986; 64: 581–6.
  • 6
    Wauben MH. Immunological mechanisms involved in experimental peptide immunotherapy of T-cell-mediated diseases. Crit Rev Immunol 2000; 20: 451–69.
  • 7
    Joosten LA, Coenen-de Roo CJ, Helsen MM, Lubberts E, Boots AM, van den Berg WB, et al. Induction of tolerance with intranasal administration of human cartilage gp-39 in DBA/1 mice: amelioration of clinical, histologic, and radiologic signs of type II collagen-induced arthritis. Arthritis Rheum 2000; 43: 645–55.
    Direct Link:
  • 8
    Staines NA, Harper N, Ward FJ, Malmström V, Holmdahl R, Bansal S. Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitope. Clin Exp Immunol 1996; 103: 368–75.
    Direct Link:
  • 9
    Daniel D, Wegmann DR. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9–23). Proc Natl Acad Sci U S A 1996; 93: 956–60.
  • 10
    Prakken BJ, van der Zee R, Anderton SM, van Kooten PJS, Kuis W, van Eden W. Peptide-induced nasal tolerance for a mycobacterial heat shock protein 60 T cell epitope in rats suppresses both adjuvant arthritis and nonmicrobially induced experimental arthritis. Proc Natl Acad Sci U S A 1997; 94: 3284–9.
  • 11
    Holoshitz J, Naparstek Y, Ben-Nun A, Cohen IR. Lines of T lymphocytes induce or vaccinate against autoimmune arthritis. Science 1983; 219: 56–8.
  • 12
    Van Eden W, Thole JE, van der Zee R, Noordzij A, van Embden JD, Hensen EJ, et al. Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature 1988; 331: 171–3.
  • 13
    Wauben MHM, Boog CJP, van der Zee R, Joosten I, Schlief A, van Eden W. Disease inhibition by major histocompatibility complex binding peptide analogues of disease-associated epitopes: more than blocking alone. J Exp Med 1992; 76: 667–77.
  • 14
    Wauben MHM, van der Zee R, Joosten I, Boog CJP, van Dijk AMC, Holewijn M, et al. A peptide variant of an arthritis-related T cell epitope induces T cells that recognizes this epitope as a synthetic peptide but not in its naturally processed form. J Immunol 1993; 150: 5722–30.
  • 15
    Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, et al. M-G: a CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997; 389: 737–42.
  • 16
    Anderton SM, van der Zee R, Noordzij A, van Eden W. Differential mycobacterial 65-kDa heat shock protein T cell epitope recognition after adjuvant arthritis-inducing or protective immunization protocols. J Immunol 1994; 152: 3656–64.
  • 17
    Joosten I, Wauben MH, Holewijn MC, Reske K, Pedersen LO, Roosenboom CFP, et al. Direct binding of autoimmune disease related T cell epitopes to purified Lewis rat MHC class II molecules. Int Immunol 1994; 6: 751–9.
  • 18
    Miller A, al-Sabbagh A, Santos LM, Das MP, Weiner HL. Epitopes of myelin basic protein that trigger TGF-β release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression. J Immunol 1993; 51: 7307–15.
  • 19
    Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen: an experimental model of arthritis. J Exp Med 1977; 146: 857–68.
  • 20
    Miller A, Lider O, Roberts MB, Sporn MB, Weiner HL. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor α after antigen-specific triggering. Proc Natl Acad Sci U S A 1992; 89: 421–5.
  • 21
    Das MP, Nicholson LB, Greer JM, Kuchroo VK. Autopathogenic T helper cell type 1 (Th1) and protective Th2 clones differ in their recognition of the autoantigenic peptide of myelin proteolipid protein. J Exp Med 1997; 186: 867–76.
  • 22
    Nicholson LB, Waldner H, Carrizosa AM, Sette A, Collins M, Kuchroo VK. Heteroclitic proliferative responses and changes in cytokine profile induced by altered peptides: implications for autoimmunity. Proc Natl Acad Sci U S A 1998; 95: 264–9.
  • 23
    Wauben MH, van der Kraan M, Grosfeld-Stulemeyer MC, Joosten I. Definition of an extended MHC class II-peptide binding motif for the autoimmune disease-associated Lewis rat RT1.Bl molecule. Int Immunol 1997; 9: 281–90.
  • 24
    Liu GY, Wraith DC. Affinity for class II MHC determines the extent to which soluble peptides tolerize autoreactive T cells in naive and primed adult mice: implications for autoimmunity. Int Immunol 1995; 7: 1255–63.
  • 25
    Anderton SM, Wraith DC. Hierarchy in the ability of T cell epitopes to induce peripheral tolerance to antigens from myelin. Eur J Immunol 1998; 28: 1251–61.
    Direct Link:
  • 26
    Nicholson LB, Murtaza A, Hafler BP, Sette A, Kuchroo VK. A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigens. Proc Natl Acad Sci U S A 1997; 94: 9279–84.
  • 27
    Smeltz RB, Wauben MHM, Wolf NA, Swanborg RH. Critical requirement for aspartic acid at position 82 of myelin basic protein 73-86 for recruitment of Vβ 8.2+ T cells and encephalitogenicity in the Lewis rat. J Immunol 1999; 162: 829–36.
  • 28
    Wolvers DAE, van der Cammen AG, Kraal G. Mucosal tolerance is associated with, but independent of, the up-regulation of Th2 responses. Immunology 1997; 92: 32833–6.
    Direct Link:
  • 29
    Chen Y, Inobe J, Marks R, Gonnella P, Kuchroo VK, Weiner HL. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 1995; 376: 177–80.
  • 30
    Weiner HL. The mucosal milieu creates tolerogenic dendritic cells and T(R)1 and T(H)3 regulatory cells. Nat Immunol 2001; 2: 671–2.
  • 31
    Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994;265: 1237–40.
  • 32
    Bayrak S, Mitchison NA. Bystander suppression of murine collagen-induced arthritis by long-term nasal administration of a self type II collagen peptide. Clin Exp Immunol 1998; 113: 92–5.
    Direct Link:
  • 33
    Myers LK, Seyer JM, Stuart JM, Kang AH. Suppression of murine collagen-induced arthritis by nasal administration of collagen. Immunology 1997; 90: 161–4.
    Direct Link:
  • 34
    Tian Y, Atkinson MA, Clare-Salzler M, Herschenfeld A, Forsthuber T, Lehmann PV, et al. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J Exp Med 1996; 183: 1561–7.
  • 35
    Hoyne GF, Jarnicki AG, Thomas WR, Lamb JR. Characterization of the specificity and duration of T cell tolerance to intranasally administered peptides in mice: a role for intramolecular epitope suppression. Int Immunol 1997; 9: 1165–73.
  • 36
    Bettelli E, Das MP, Howard ED, Weiner HL, Sobel RA, Kuchroo VK. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J Immunol 1998; 161: 3299–306.
  • 37
    Johansson AC, Hansson AS, Nandakumar KS, Backlund J, Holmdahl R. IL-10-deficient B10.Q mice develop more severe collagen-induced arthritis, but are protected from arthritis induced with anti-type II collagen antibodies. J Immunol 2001; 167: 3505–12.
View Full Article (HTML) Get PDF (208K)